Simon Castleden

626 total citations
6 papers, 537 citations indexed

About

Simon Castleden is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Simon Castleden has authored 6 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Simon Castleden's work include Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (3 papers). Simon Castleden is often cited by papers focused on Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (3 papers). Simon Castleden collaborates with scholars based in United Kingdom, Canada and United States. Simon Castleden's co-authors include Richard G. Vile, Heung Chong, Ian R. Hart, J. Arly Nelson, John F. Marshall, Richard S. Camplejohn, Carol Upton, Bruce Roberts, R G Vile and H. Chong and has published in prestigious journals such as International Journal of Cancer, Biochemical Society Transactions and Human Gene Therapy.

In The Last Decade

Simon Castleden

6 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Castleden United Kingdom 5 409 295 197 155 118 6 537
Singh Gagandeep United States 6 358 0.9× 237 0.8× 149 0.8× 73 0.5× 107 0.9× 7 494
R L Martuza United States 12 704 1.7× 436 1.5× 377 1.9× 163 1.1× 104 0.9× 13 916
Jennifer Coleman United States 11 447 1.1× 266 0.9× 405 2.1× 140 0.9× 45 0.4× 19 677
Luke Russell United States 11 370 0.9× 294 1.0× 329 1.7× 172 1.1× 49 0.4× 19 648
F. Lang United States 6 238 0.6× 309 1.0× 229 1.2× 53 0.3× 56 0.5× 7 467
M. J. Uprichard United States 8 323 0.8× 292 1.0× 421 2.1× 49 0.3× 88 0.7× 18 597
Melinda Van Roey United States 8 450 1.1× 385 1.3× 180 0.9× 42 0.3× 33 0.3× 9 566
Maxine Bauzon United States 12 397 1.0× 303 1.0× 361 1.8× 77 0.5× 89 0.8× 25 606
Petri Nokisalmi Finland 8 355 0.9× 208 0.7× 318 1.6× 83 0.5× 95 0.8× 12 470
Jianfang Ning United States 10 218 0.5× 293 1.0× 297 1.5× 77 0.5× 52 0.4× 18 563

Countries citing papers authored by Simon Castleden

Since Specialization
Citations

This map shows the geographic impact of Simon Castleden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Castleden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Castleden more than expected).

Fields of papers citing papers by Simon Castleden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Castleden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Castleden. The network helps show where Simon Castleden may publish in the future.

Co-authorship network of co-authors of Simon Castleden

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Castleden. A scholar is included among the top collaborators of Simon Castleden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Castleden. Simon Castleden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Vile, Richard G., Simon Castleden, John F. Marshall, et al.. (1997). Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. International Journal of Cancer. 71(2). 267–274. 165 indexed citations
2.
Castleden, Simon, Heung Chong, Ignacio Garcia‐Ribas, et al.. (1997). A Family of Bicistronic Vectors to Enhance Both Local and Systemic Antitumor Effects of HSVtk or Cytokine Expression in a Murine Melanoma Model. Human Gene Therapy. 8(17). 2087–2102. 37 indexed citations
3.
Vile, Richard G., Simon Castleden, John C. Marshall, et al.. (1997). Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression. International Journal of Cancer. 71(2). 267–274. 3 indexed citations
4.
Vile, R G, Rosa María Díaz, Simon Castleden, & H. Chong. (1997). Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Biochemical Society Transactions. 25(2). 717–722. 21 indexed citations
5.
Vile, Richard G., et al.. (1996). Retroviral vectors. Molecular Biotechnology. 5(2). 139–158. 44 indexed citations
6.
Vile, Richard G., J. Arly Nelson, Simon Castleden, Heung Chong, & Ian R. Hart. (1994). Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.. PubMed. 54(23). 6228–34. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026